<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/09014666-EFE1-4DF4-BDD7-DDE7D8A1AADB"><gtr:id>09014666-EFE1-4DF4-BDD7-DDE7D8A1AADB</gtr:id><gtr:name>University of Rennes 1</gtr:name><gtr:address><gtr:line1>Universite de Rennes 1</gtr:line1><gtr:line2>2 rue du Thabor</gtr:line2><gtr:line3>CS 46510</gtr:line3><gtr:line4>Rennes</gtr:line4><gtr:postCode>35065</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>France</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/A0A585E0-6B0D-4643-A3A6-47943B4CBFEF"><gtr:id>A0A585E0-6B0D-4643-A3A6-47943B4CBFEF</gtr:id><gtr:name>University of Liverpool</gtr:name><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line2>Abercromby Square</gtr:line2><gtr:line4>Liverpool</gtr:line4><gtr:postCode>L69 3BX</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/5E2B04DD-4A03-45ED-9892-61C5CCB8AC68"><gtr:id>5E2B04DD-4A03-45ED-9892-61C5CCB8AC68</gtr:id><gtr:name>Newcastle University</gtr:name><gtr:address><gtr:line1>1 Park Terrace</gtr:line1><gtr:line4>Newcastle Upon Tyne</gtr:line4><gtr:line5>Tyne and Wear</gtr:line5><gtr:postCode>NE1 7RU</gtr:postCode><gtr:region>North East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/03D8AFBB-3EA5-4885-B036-BD4F9F4F9849"><gtr:id>03D8AFBB-3EA5-4885-B036-BD4F9F4F9849</gtr:id><gtr:name>University of Sheffield</gtr:name><gtr:department>Biomedical Science</gtr:department><gtr:address><gtr:line1>Firth Court</gtr:line1><gtr:line2>Western Bank</gtr:line2><gtr:line4>Sheffield</gtr:line4><gtr:line5>South Yorkshire</gtr:line5><gtr:postCode>S10 2TN</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/03D8AFBB-3EA5-4885-B036-BD4F9F4F9849"><gtr:id>03D8AFBB-3EA5-4885-B036-BD4F9F4F9849</gtr:id><gtr:name>University of Sheffield</gtr:name><gtr:address><gtr:line1>Firth Court</gtr:line1><gtr:line2>Western Bank</gtr:line2><gtr:line4>Sheffield</gtr:line4><gtr:line5>South Yorkshire</gtr:line5><gtr:postCode>S10 2TN</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/09014666-EFE1-4DF4-BDD7-DDE7D8A1AADB"><gtr:id>09014666-EFE1-4DF4-BDD7-DDE7D8A1AADB</gtr:id><gtr:name>University of Rennes 1</gtr:name><gtr:address><gtr:line1>Universite de Rennes 1</gtr:line1><gtr:line2>2 rue du Thabor</gtr:line2><gtr:line3>CS 46510</gtr:line3><gtr:line4>Rennes</gtr:line4><gtr:postCode>35065</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>France</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/A0A585E0-6B0D-4643-A3A6-47943B4CBFEF"><gtr:id>A0A585E0-6B0D-4643-A3A6-47943B4CBFEF</gtr:id><gtr:name>University of Liverpool</gtr:name><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line2>Abercromby Square</gtr:line2><gtr:line4>Liverpool</gtr:line4><gtr:postCode>L69 3BX</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/5E2B04DD-4A03-45ED-9892-61C5CCB8AC68"><gtr:id>5E2B04DD-4A03-45ED-9892-61C5CCB8AC68</gtr:id><gtr:name>Newcastle University</gtr:name><gtr:address><gtr:line1>1 Park Terrace</gtr:line1><gtr:line4>Newcastle Upon Tyne</gtr:line4><gtr:line5>Tyne and Wear</gtr:line5><gtr:postCode>NE1 7RU</gtr:postCode><gtr:region>North East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/DCAABCD2-C89D-4D70-A36B-59D65882D985"><gtr:id>DCAABCD2-C89D-4D70-A36B-59D65882D985</gtr:id><gtr:firstName>Gaynor</gtr:firstName><gtr:surname>Miller</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/281F9E19-F665-4E1E-B639-604476906BA4"><gtr:id>281F9E19-F665-4E1E-B639-604476906BA4</gtr:id><gtr:firstName>Steve</gtr:firstName><gtr:surname>Winder</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=G0701129"><gtr:id>F71283FC-EC5A-463D-AD87-8CA6D5DF9F9D</gtr:id><gtr:title>Regulation of dystroglycan function by tyrosine phosphorylation: implications for muscular dystrophy</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0701129</gtr:grantReference><gtr:abstractText>Dystroglycan is a protein that links the inside of individual cells of the body with their outside environment. In doing this dystroglycan has a stabilising role in the cell and helps to prevent damage when cells are under stress. One example is when dystroglycan is lost from muscles cells, such as in several muscular dystrophies, here the muscle cells are more easily damaged and die. Besides this stabilising role, dystroglycan is also able to transduce signals that regulate the shape and stability of all cells. Dystroglycan is therefore of fundamental importance in maintaining connections between cells, in governing cell shape and also in determining cell polarity i.e. knowing top from bottom and front from back. As a consequence of these functions dystroglycan is important for cell viability and is required to form tissues, dystroglycan also acts as a point for some bacteria and viruses to gain entry to the cells. This research will address the way in which dystroglycan is able to send and receive signals, and the interactions that dystroglycan has with other proteins that are important for its function. We hope to apply this basic knowledge of dystroglycan function to understanding diseases including muscular dystrophy and cancer.</gtr:abstractText><gtr:technicalSummary>Dystroglycan is a ubiquitous and essential cell adhesion molecule, the functions of which are now beginning to be revealed. The main aims of the project are to define the role of dystroglycan tyrosine phosphorylation in regulating its function at the plasma membrane, and to investigate the potential protective effect of preventing dystroglycan phosphorylation in mouse models of muscular dystrophy. We will utilise a broad range of molecular and cell biological tools at our disposal to elucidate dystroglycan function, including; biochemical, cell biological, spatio-temporal imaging, and over-expression, knockdown and transgenic approaches. An integrated approach will provide an in-depth and systematic analysis of dystroglycan function at the cell biological and tissue level. This will not only further our understanding of the roles of this fundamentally important cell adhesion molecule, but also provide insight into the aetiology and possible therapies for conditions where dystroglycan function is altered e.g. muscular dystrophies and cancer.</gtr:technicalSummary><gtr:fund><gtr:end>2012-01-31</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2008-10-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>447174</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Rennes 1 (Universit? de Rennes 1)</gtr:collaboratingOrganisation><gtr:country>France, French Republic</gtr:country><gtr:department>Faculty of Medicine</gtr:department><gtr:description>Dystroglcyan-actin-membrance interactions</gtr:description><gtr:id>E11091A1-BB4B-4362-A400-F408827ACB22</gtr:id><gtr:impact>Significant review incorporating new hypothesis on dystrophin glycoprotein complex organisation</gtr:impact><gtr:partnerContribution>Stimulating scientific discourse</gtr:partnerContribution><gtr:piContribution>Provision of reagents and technical expertise,</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Liverpool</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>CIMA</gtr:description><gtr:id>BC60A76F-B5E8-4FBA-8FA2-789024FD3572</gtr:id><gtr:impact>The joint bid for the Centre for Integrated research in Musckuloskeletal Ageing (CIMA) was funded in full in November 2011</gtr:impact><gtr:partnerContribution>early days, too soon to say</gtr:partnerContribution><gtr:piContribution>Contributed to the application by Liverpool, Sheffield and Newcastle to the MRC/ARUK call for centres in musculoskeletal ageing.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Newcastle University</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>CIMA</gtr:description><gtr:id>292D01FF-D623-46ED-BDA2-9A2EA27FCFCB</gtr:id><gtr:impact>The joint bid for the Centre for Integrated research in Musckuloskeletal Ageing (CIMA) was funded in full in November 2011</gtr:impact><gtr:partnerContribution>early days, too soon to say</gtr:partnerContribution><gtr:piContribution>Contributed to the application by Liverpool, Sheffield and Newcastle to the MRC/ARUK call for centres in musculoskeletal ageing.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>AD NAtional Conference</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>1647D6F0-635C-4628-92E5-52DD5D927D51</gtr:id><gtr:impact>A lot of interest from the DMD community on the clinical potential of our research and the benefits in treating DMD sufferers

Severl requests for further information from members of the public, interest in visiting my lab,offers of funding</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Yorkshire Post Interview</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>1D274EC5-9BFD-4B69-8748-86A72ADDD67E</gtr:id><gtr:impact>Gave an interview on our research activity in area of DMD and how this could benefit a local boy with the disease

not known</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:url>http://www.yorkshirepost.co.uk/news/at-a-glance/general-news/family-to-fund-fight-against-muscle-condition-1-5488291</gtr:url><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Radio Sheffield</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>6B714E9E-A177-4D46-9867-566A7D09D41A</gtr:id><gtr:impact>Invited to give an interview to Radio Sheffield as a local 'expert' along with a representative of the charity Muscular Dystrophy Campaign and local fund raiser.

Difficult to judge, but apparently was very well received</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>MDC National Conference 2013</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>1BC95C7E-2C45-44D6-9B32-0ABF2E1E7811</gtr:id><gtr:impact>Gave poster presentation and led/facilitated workshop discussion to carers and sufferers of DMD at the MDC national conference.

too soon to tell</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:url>http://www.muscular-dystrophy.org/</gtr:url><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>MDC National fund launch</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>BFF06C49-D66D-4E16-99B2-8BD4B3B63B87</gtr:id><gtr:impact>30 parents and carers of chldren with DMD attended, asked questions, engaged in discsussion.

Resulted in one local family setting up their own charitable fund to support [our] DMD research in Sheffield</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>MDC AGM</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>C9D9A9DA-C9F5-4593-BDD8-481E025BDFF3</gtr:id><gtr:impact>Presented poster of our work and talked directly to patients carers and families of people with muscular dystrophy

My students' poster won the science communication prize at this lay conference in 2011</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2010,2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>MDC DMD day</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>AE0EACEB-74D2-44BE-88EB-983A50ED9387</gtr:id><gtr:impact>A lot of interst and informal questioning from parents and carers of people living with DMD

Direct approach from a charity to offer to fund my research</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>School visit</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>16C54844-980F-4722-9E99-558F3CF6DDA3</gtr:id><gtr:impact>Received a charity donation cheque for MDC in front of whole school assembly of 500 children, brief dsicussion of our research. Photo shoot with class of 30 including two chidren with muscular dystrophy

Heightened awareness of research and disease by all pupils, I am now recognsied as a 'scientist' bu pupils at the school, and even in the street!</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>103133</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Muscular Dystrophy Campaign Studentship</gtr:description><gtr:end>2013-08-02</gtr:end><gtr:fundingOrg>Muscular Dystrophy UK</gtr:fundingOrg><gtr:fundingRef>RA4/806</gtr:fundingRef><gtr:id>85C841ED-7817-4305-B59B-87D9FB477F39</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>121000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Action Duchenne Project Grant</gtr:description><gtr:end>2017-10-02</gtr:end><gtr:fundingOrg>Action Duchenne</gtr:fundingOrg><gtr:id>5C697815-08F8-4D6E-8A3A-6B523E4BF17D</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>216426</gtr:amountPounds><gtr:country>Netherlands, Kingdom of the</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:description>Duchenne Parent Project NL Project Grant</gtr:description><gtr:end>2015-04-02</gtr:end><gtr:fundingOrg>Duchenne Parent Project Holland</gtr:fundingOrg><gtr:id>CE1DD7FE-7B41-44A0-AFA4-C0011502E949</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-05-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>Use of tyrosine kinase inhibitors as a treatment for DMD</gtr:description><gtr:id>F141DE22-9C5F-4728-9B42-DA02843962B6</gtr:id><gtr:impact>none</gtr:impact><gtr:licensed>No</gtr:licensed><gtr:patentId>PCT/GB2013/051849</gtr:patentId><gtr:protection>Patent application published</gtr:protection><gtr:title>Treatment of muscular dystrophy</gtr:title><gtr:yearProtectionGranted>2014</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Knockin mouse at Y890 of DAG1 gene</gtr:description><gtr:id>525E7836-51FB-467F-A554-6A4003F65F2B</gtr:id><gtr:impact>When above crossed onto mdx dystrophic background get significant amelioration of dystrophic symptoms</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>DAG1 Y890F mouse</gtr:title><gtr:type>Model of mechanisms or symptoms - mammalian in vivo</gtr:type><gtr:yearFirstProvided>2014</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/7AA91B1A-FF25-4A01-9518-8F557EEF3D0B"><gtr:id>7AA91B1A-FF25-4A01-9518-8F557EEF3D0B</gtr:id><gtr:title>The proteasomal inhibitor MG132 prevents muscular dystrophy in zebrafish.</gtr:title><gtr:parentPublicationTitle>PLoS currents</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c77d9fb04e6e8c9b5c3b222d9aedd208"><gtr:id>c77d9fb04e6e8c9b5c3b222d9aedd208</gtr:id><gtr:otherNames>Winder SJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/EA106ADD-D00B-4892-BB74-65801C7F1186"><gtr:id>EA106ADD-D00B-4892-BB74-65801C7F1186</gtr:id><gtr:title>Dystroglycan versatility in cell adhesion: a tale of multiple motifs.</gtr:title><gtr:parentPublicationTitle>Cell communication and signaling : CCS</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/d0eb92add8dcfb988911ae06810c5323"><gtr:id>d0eb92add8dcfb988911ae06810c5323</gtr:id><gtr:otherNames>Moore CJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1478-811X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/696AF2DC-AE1E-4082-9D51-94BC1A8164D8"><gtr:id>696AF2DC-AE1E-4082-9D51-94BC1A8164D8</gtr:id><gtr:title>Modulation of cell spreading and cell-substrate adhesion dynamics by dystroglycan.</gtr:title><gtr:parentPublicationTitle>Journal of cell science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/9bb4d8c3dc9e6e1c8ba421709202e3d1"><gtr:id>9bb4d8c3dc9e6e1c8ba421709202e3d1</gtr:id><gtr:otherNames>Thompson O</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0021-9533</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/291D9C06-C952-4F75-A5A7-F67A6409A19C"><gtr:id>291D9C06-C952-4F75-A5A7-F67A6409A19C</gtr:id><gtr:title>Preventing phosphorylation of dystroglycan ameliorates the dystrophic phenotype in mdx mouse.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/529658a9cdd14ca4e07f174b9c438cce"><gtr:id>529658a9cdd14ca4e07f174b9c438cce</gtr:id><gtr:otherNames>Miller G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/F89910EB-D264-42D0-B97C-7B876AE0E2BF"><gtr:id>F89910EB-D264-42D0-B97C-7B876AE0E2BF</gtr:id><gtr:title>Dystrophin: more than just the sum of its parts.</gtr:title><gtr:parentPublicationTitle>Biochimica et biophysica acta</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c2b3a5e0ef9de3293a4ebc4400433d97"><gtr:id>c2b3a5e0ef9de3293a4ebc4400433d97</gtr:id><gtr:otherNames>Le Rumeur E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0006-3002</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/29EEC7A6-A51D-4888-B02C-CFF143838122"><gtr:id>29EEC7A6-A51D-4888-B02C-CFF143838122</gtr:id><gtr:title>Thermodynamic stability, unfolding kinetics, and aggregation of the N-terminal actin-binding domains of utrophin and dystrophin.</gtr:title><gtr:parentPublicationTitle>Proteins</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/786990c216cdc17acd648535f4d6a963"><gtr:id>786990c216cdc17acd648535f4d6a963</gtr:id><gtr:otherNames>Singh SM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0887-3585</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/B2F8FB98-613F-4951-8DBA-31B1C88A8BEF"><gtr:id>B2F8FB98-613F-4951-8DBA-31B1C88A8BEF</gtr:id><gtr:title>A new twist to coiled coil.</gtr:title><gtr:parentPublicationTitle>FEBS letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c2b3a5e0ef9de3293a4ebc4400433d97"><gtr:id>c2b3a5e0ef9de3293a4ebc4400433d97</gtr:id><gtr:otherNames>Le Rumeur E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0014-5793</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A34B8309-1B37-4F16-B009-F52784276398"><gtr:id>A34B8309-1B37-4F16-B009-F52784276398</gtr:id><gtr:title>The inside and out of dystroglycan post-translational modification.</gtr:title><gtr:parentPublicationTitle>Neuromuscular disorders : NMD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/d0eb92add8dcfb988911ae06810c5323"><gtr:id>d0eb92add8dcfb988911ae06810c5323</gtr:id><gtr:otherNames>Moore CJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0960-8966</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0701129</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>7C58A707-1BF6-4573-A44F-30B271C80813</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Cancer</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>149FA87E-B8CD-4FFC-B515-EAD312BED03B</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Musculoskeletal</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>